Veradigm INC

Veradigm Inc. has extended its Stockholder Agreement with Charles and Jessica Myers, maintaining board observer status through December 31, 2026.

Veradigm Inc. has entered into a consulting agreement with Leland Westerfield and Wilcox Capital LLC to provide strategic financial advisory services through March 31, 2027.

Veradigm Inc. announced the filing of its Annual Reports on Form 10-K for fiscal years 2023 and 2024, marking a significant step towards regaining current SEC filing status.

Veradigm Inc. announced the appointment of Christian Greyenbuhl as its new Chief Financial Officer, effective May 11, 2026, or later, as the company works to become current with its SEC filings.

The SEC has concluded its investigation into Veradigm Inc. and its former executives, stating no enforcement action will be recommended.

Veradigm Inc. has extended its Stockholder Rights Plan, also known as a 'poison pill,' until December 31, 2026, citing ongoing risks and the need to protect shareholder value.

Veradigm Inc. has filed its annual report for the fiscal year ended December 31, 2024, detailing a significant revenue decrease, substantial goodwill impairment, and ongoing material weaknesses in internal controls.

Veradigm's recent 10-K filing details a period marked by financial restatements, leadership changes, and strategic realignments, including a shift towards a standalone strategy after exploring strategic alternatives.

Director Jonathan Sacks was granted 42,507 restricted stock units in Veradigm Inc. as part of the company's 2024 Stock Incentive Plan.

Stonehill Capital Management and associated directors received restricted stock unit grants under the 2024 Stock Incentive Plan.

Veradigm Inc. reports a Form 4 filing detailing the acquisition of Restricted Stock Units by Director Carol J. Zierhoffer.

Veradigm Inc. Director Susan Rodriguez reported the acquisition of 42,507 shares of common stock on June 1, 2026, through an award of Restricted Stock Units.

Veradigm Inc. reports a Form 4 filing detailing the acquisition of common stock by Director Lou Silverman.

Veradigm Inc. director David B. Stevens was granted 42,507 Restricted Stock Units on June 1, 2026, as part of the company's 2024 Stock Incentive Plan.

Stonehill Capital Management LLC and its affiliates have significantly increased their beneficial ownership in Veradigm Inc. to 19.6% and appointed a Stonehill partner, Jonathan Sacks, to the company's Board of Directors.

Stonehill Capital Management and its affiliates have disclosed a 19.6% beneficial ownership stake in Veradigm Inc., totaling 21.14 million shares, acquired for $149.7 million, and indicate potential engagement with the company's board regarding governance and value maximization.

Two Seas Capital LP has filed an amended Schedule 13G reporting an 8.2% beneficial ownership stake in Veradigm Inc.

TD entities, including TD Bank and TD Securities (USA) LLC, have reported beneficial ownership of Veradigm Inc. common stock.

Silver Point Capital, L.P. and associated individuals have filed an exit statement for their beneficial ownership of Veradigm Inc. common stock, reporting 3.27% ownership as of March 31, 2026.

TD Bank Group entities, including Toronto Dominion Bank and TD Securities (USA) LLC, have reported a combined beneficial ownership of 6.6% in Veradigm Inc. common stock.

A group of investment entities led by Eli Samaha has disclosed a 6.6% beneficial ownership stake in healthcare technology company Veradigm Inc.

Mason Capital Management and its principals have disclosed a 5.8% beneficial ownership stake in Veradigm Inc., totaling 6,283,161 shares.